According to a press release issued by Dr Reddy’s, which began distributing the first “vaccine-like” drug against RSV, “In 2019, there were approximately 33 million cases of acute lower respiratory infections globally, leading to more than 3 million hospitalisations, and it was estimated that there were 26,300 in-hospital deaths of children younger than 5 years.”